The FASEB Journal · 2005 · 230 citations · 38 references
Life SciencesGeneticsMolecular GeneticsBiochemical GeneticsHuman GeneticsMedical GeneticsInborn Errors Of MetabolismLipid Metabolism DisordersEnzyme Gene VariantsGenetic Liver DiseaseMetabolic Enzyme PolymorphismMutationPhosphatidylcholine MetabolismSingle-nucleotide Polymorphism AnalysisSingle-nucleotide Polymorphism VariationTransgenic Mice
ABSTRACT Phosphatidylethanolamine N ‐methyltransferase (PEMT) catalyzes phosphatidylcholine synthesis. PEMT knockout mice have fatty livers, and it is possible that, in humans, nonalcoholic fatty liver disease (NAFLD) might be associated with PEMT gene polymorphisms. DNA samples from 59 humans without fatty liver and from 28 humans with NAFLD were genotyped for a single nucleotide polymorphism in exon 8 of PEMT , which leads to a V175M substitution. V175M is a loss of function mutation, as determined by transiently transfecting McArdle‐RH7777 cells with constructs of wild‐type PEMT open reading frame or the V175M mutant. Met/Met at residue 175 (loss of function SNP) occurred in 67.9% of the NAFLD subjects and in only 40.7% of control subjects ( P <0.03). For the first time we report that a polymorphism of the human PEMT gene (V175M) is associated with diminished activity and may confer susceptibility to NAFLD. Song, J., da Costa, K. A., Fischer, L. M., Kohlmeier, M., Kwock, L., Wang, S., Zeisel, S. H. Polymorphism of the PEMT gene and susceptibility to nonalcoholic fatty liver disease (NAFLD). FASEB J. 19, 1266–1271 (2005)
38
Simple proton spectroscopic imaging.
W. Thomas Dixon · Radiology · 1984 · 2.3K citations
Choline, an essential nutrient for humans
Steven H. Zeisel, Kerry-Ann da Costa, Peter Franklin et al. · The FASEB Journal · 1991 · 623 citations